Novel pyrrolopyrimidine-based α-helix mimetics: cell-permeable inhibitors of protein−protein interactions

J Am Chem Soc. 2011 Feb 2;133(4):676-9. doi: 10.1021/ja108230s.

Abstract

There is considerable interest in developing non-peptidic, small-molecule α-helix mimetics to disrupt α-helix-mediated protein−protein interactions. Herein, we report the design of a novel pyrrolopyrimidine-based scaffold for such α-helix mimetics with increased conformational rigidity. We also developed a facile solid-phase synthetic route that is amenable to divergent synthesis of a large library. Using a fluorescence polarization-based assay, we identified cell-permeable, dual MDMX/MDM2 inhibitors, demonstrating that the designed molecules can act as α-helix mimetics.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Biomimetic Materials / chemical synthesis
  • Biomimetic Materials / chemistry
  • Biomimetic Materials / metabolism*
  • Biomimetic Materials / pharmacology*
  • Cell Line, Tumor
  • Drug Design
  • High-Throughput Screening Assays
  • Humans
  • Models, Molecular
  • Permeability
  • Protein Binding / drug effects
  • Protein Structure, Secondary
  • Proto-Oncogene Proteins c-mdm2 / metabolism*
  • Pyrimidines / chemistry*
  • Pyrroles / chemistry*
  • Tumor Suppressor Protein p53 / chemistry
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Pyrimidines
  • Pyrroles
  • Tumor Suppressor Protein p53
  • pyrrolopyrimidine
  • Proto-Oncogene Proteins c-mdm2